Abstract
Background/Objectives: Rapid molecular point-of-care testing (mPOCT) can provide respiratory pathogen results within clinically actionable timeframes, yet implementation in emergency departments remains inconsistent. This project report aimed to examine the perceived clinical, operational, and organizational value of rapid mPOCT in emergency respiratory care and to identify key barriers and enablers to its implementation. Methods: A multidisciplinary group of point-of-care testing experts from Germany, France, Saudi Arabia, and the United Kingdom participated in sounding-board discussions, interviews, and questionnaires. Consultation outputs were synthesized from structured notes, descriptive questionnaire summaries, and facilitated discussion, and were then mapped deductively to the Consolidated Framework for Implementation Research to structure implementation-related findings. Results: Experts identified rapid mPOCT as a potentially valuable tool for supporting timely diagnosis, targeted treatment, infection-control decisions, patient flow, cohorting, and resource utilization. However, implementation was considered to be limited by insufficient awareness of clinical and economic value, the absence of standardized pathways, logistical and information-technology challenges, and fragmented integration into hospital workflows. The group emphasized the need for clearer implementation guidance, stronger evidence generation, improved communication of health-economic value, and closer collaboration among clinical, laboratory, industry, and policy stakeholders. Conclusions: Rapid mPOCT may support emergency respiratory care by providing clinically actionable results within shorter timeframes, but its value depends on local implementation context. Its wider adoption may depend not only on test performance, but also on standardized pathways, organizational readiness, stakeholder engagement, and practical implementation support.